XEN Gel Stent in Medically Refractory Open-Angle Glaucoma: Results and Observations After One Year of Use in the United States.

Introduction: The purpose of this study was to evaluate intraocular pressure (IOP) lowering and safety of XEN stent in medically refractory, progressive, open-angle glaucoma (OAG).

Methods: Forty-seven eyes of 42 patients were treated with XEN stent alone or combined with phacoemulsification.

Results: Mean IOP decreased from 22.